<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00562991</url>
  </required_header>
  <id_info>
    <org_study_id>B30020072436</org_study_id>
    <nct_id>NCT00562991</nct_id>
  </id_info>
  <brief_title>Monitoring Asthma Treatment Using Exhaled Nitric Oxide</brief_title>
  <acronym>NOASTHMA</acronym>
  <official_title>Monitoring Asthma Treatment Using Exhaled Nitric Oxide</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Antwerp</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Merck Sharp &amp; Dohme Corp.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aerocrine AB</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital, Antwerp</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Asthma is a chronic inflammatory condition in which the airways develop increased&#xD;
      responsiveness to various stimuli such as exposure to an allergen, cold air or exercise. It&#xD;
      is characterized by airway hyper-responsiveness, inflammation, increased mucus production,&#xD;
      and airway obstruction. Since inflammation is an important feature of asthma, the use of&#xD;
      non-invasive tests to measure lung inflammation to monitor asthma are of interest.The purpose&#xD;
      of the study is to relate costs associated with healthcare utilization and loss of work and&#xD;
      school time to the primary health outcome of cumulative number of symptom-free days. This&#xD;
      will enable the researchers to determine whether the costs of monitoring exhaled NO to&#xD;
      regular management strategy in recently diagnosed asthma will be offset by reductions in&#xD;
      other costs of asthma-related care, and, if not, whether the additional costs are likely to&#xD;
      be acceptable in terms of the improvement in health outcomes as measured by the additional&#xD;
      number of symptom-free days.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2007</start_date>
  <completion_date type="Actual">December 2009</completion_date>
  <primary_completion_date type="Actual">October 1, 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>symptom-free days</measure>
    <time_frame>1 year time frame with visits every 3 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>days spent in hospital,emergency room visits,physician or nurse contacts use of drugs, days on which school was missed, number of exacerbations</measure>
    <time_frame>1 year time frame</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">99</enrollment>
  <condition>Asthma</condition>
  <arm_group>
    <arm_group_label>FeNO group</arm_group_label>
    <description>asthma patients, exhaled NO is used to monitor asthma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Symptom group</arm_group_label>
    <description>asthma patients, exhaled NO is not used to monitor asthma</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>measurement of exhaled NO is used to guide treatment</intervention_name>
    <description>exhaled NO</description>
    <arm_group_label>FeNO group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        asthmatic children&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female children, aged 6-14 years&#xD;
&#xD;
          -  A documented history of asthma for a period of at least 6 months&#xD;
&#xD;
          -  Mild to severe persistent asthma according to GINA guidelines&#xD;
&#xD;
          -  A documented history of allergic sensitization (positive skin prick test or specific&#xD;
             IgE&#xD;
&#xD;
          -  Subject's guardian/parent should be able to complete a symptom score on behalf of the&#xD;
             subject.&#xD;
&#xD;
          -  Subject's guardian/parent should be able to send a symptom score weekly by sms&#xD;
&#xD;
          -  Both parents have to give written informed consent to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Received any investigational study medication in the 4 weeks prior to screening Visit&#xD;
&#xD;
          -  Significant comorbidity such as concurrent infection, history of prematurity, history&#xD;
             of bronchopulmonary dysplasia, cystic fibrosis, other chronic lung diseases, and other&#xD;
             severe chronic diseases&#xD;
&#xD;
          -  Acute asthma exacerbation within 4 weeks of screening visit&#xD;
&#xD;
          -  Hospitalization within 12 weeks of screening visit&#xD;
&#xD;
          -  Systemic corticosteroids within 12 weeks of screening visit&#xD;
&#xD;
          -  Oral corticosteroid dependence&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>kristine N Desager, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Antwerp</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Antwerp</name>
      <address>
        <city>Antwerp</city>
        <zip>2650</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Algemeen Ziekenhuis St Jan</name>
      <address>
        <city>Brugge</city>
        <zip>8000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ des enfants Reine Fabiola</name>
      <address>
        <city>Brussels</city>
        <zip>1020</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HÃ´pital Erasme</name>
      <address>
        <city>Brussels</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Virga Jesseziekenhuis</name>
      <address>
        <city>Hasselt</city>
        <zip>3500</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Algemeen ziekenhuis Turnhout, Campus Sint-Jozef</name>
      <address>
        <city>Turnhout</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CH Peltzer</name>
      <address>
        <city>Verviers</city>
        <zip>4800</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>November 2007</verification_date>
  <study_first_submitted>November 21, 2007</study_first_submitted>
  <study_first_submitted_qc>November 23, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 26, 2007</study_first_posted>
  <last_update_submitted>January 25, 2021</last_update_submitted>
  <last_update_submitted_qc>January 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>exhaled NO</keyword>
  <keyword>asthma</keyword>
  <keyword>child</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

